Gestational age is related to symptoms of attention-deficit/hyperactivity disorder in late-preterm to full-term children and adolescents with down syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 11 2020
Historique:
received: 17 06 2020
accepted: 09 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 30 3 2021
Statut: epublish

Résumé

Attention-deficit/hyperactivity disorder is frequently reported in individuals with Down syndrome, with considerable variation in the expression and severity of the symptoms. Despite growing evidence that gestational age predicts later symptoms of attention-deficit/hyperactivity disorder in the euploid population, this has not been studied in down syndrome. The current study is designed to investigate the influence of gestational age in later symptoms of attention-deficit/hyperactivity disorder in 105 individuals (49 males and 56 females; aged 6-18 years) with Down syndrome who were born at or after 35 weeks gestation. Maternal age at birth, maternal level of education, household income, as well as sex, chronological age, and cognitive level of the participant with Down syndrome were considered in our analysis. Results from this study show that gestational age is related to inattentive and hyperactive/impulsive symptoms in children and adolescents with Down syndrome. Therefore, gestational age should be addressed when considering symptoms of attention-deficit/hyperactivity disorder, as it may have implications for early interventions. More attention is needed toward the advancement of care and follow-up for infants with down syndrome who are born even late preterm or early term.

Identifiants

pubmed: 33230240
doi: 10.1038/s41598-020-77392-5
pii: 10.1038/s41598-020-77392-5
pmc: PMC7683733
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20345

Subventions

Organisme : NIH HHS
ID : U54HD079125
Pays : United States
Organisme : NIH HHS
ID : P30HD03352
Pays : United States
Organisme : NIH HHS
ID : U54HD090256
Pays : United States

Références

J Neurodev Disord. 2020 Jan 23;12(1):4
pubmed: 31973697
J Am Acad Child Adolesc Psychiatry. 2017 Jun;56(6):466-474
pubmed: 28545751
J Pediatr. 2013 Mar;162(3):464-9
pubmed: 23140884
JAMA. 2010 Jul 28;304(4):419-25
pubmed: 20664042
MMWR Surveill Summ. 2018 Apr 27;67(6):1-23
pubmed: 29701730
Paediatr Perinat Epidemiol. 2015 Jan;29(1):31-40
pubmed: 25405673
Pediatrics. 2011 May;127(5):858-65
pubmed: 21502231
Am J Med Genet A. 2011 Nov;155A(11):2688-91
pubmed: 21932314
J Intellect Disabil Res. 2017 Jun;61(6):594-603
pubmed: 27862512
Dev Med Child Neurol. 2017 Mar;59(3):276-283
pubmed: 27503703
Am J Med Genet C Semin Med Genet. 2006 Aug 15;142C(3):158-72
pubmed: 16838318
J Clin Child Adolesc Psychol. 2003 Sep;32(3):328-40
pubmed: 12881022
J Appl Res Intellect Disabil. 2008 Jan;21(1):48-57
pubmed: 26246797
Am J Intellect Dev Disabil. 2017 May;122(3):215-234
pubmed: 28452581
J Am Acad Child Adolesc Psychiatry. 2009 Nov;48(11):1085-1093
pubmed: 19797980
Postgrad Med. 2010 Sep;122(5):97-109
pubmed: 20861593
J Child Neurol. 2011 Oct;26(10):1290-5
pubmed: 21628698
Semin Fetal Neonatal Med. 2014 Apr;19(2):97-104
pubmed: 24290907
Am J Med Genet A. 2013 Sep;161A(9):2188-96
pubmed: 23913657
Neurotherapeutics. 2012 Jul;9(3):490-9
pubmed: 22976615
J Autism Dev Disord. 2019 Sep;49(9):3543-3556
pubmed: 31124029
BMC Pediatr. 2010 Dec 15;10:91
pubmed: 21159164
JAMA. 2002 Aug 14;288(6):728-37
pubmed: 12169077
Am J Med Genet A. 2005 May 1;134(4):373-80
pubmed: 15759262
J Clin Child Adolesc Psychol. 2018 Mar-Apr;47(2):199-212
pubmed: 29363986
J Neurodev Disord. 2010 Sep 1;2(3):149-164
pubmed: 21274406
Dev Med Child Neurol. 2019 Aug;61(8):867-879
pubmed: 31102269
Neurosci Biobehav Rev. 2000 Jan;24(1):21-5
pubmed: 10654656
Neuroimage Clin. 2020;25:102139
pubmed: 31887718
Am J Intellect Dev Disabil. 2018 Nov;123(6):514-528
pubmed: 30421968
Arch Dis Child. 2014 Sep;99(9):834-9
pubmed: 24842798
J Clin Sleep Med. 2014 Apr 15;10(4):411-9
pubmed: 24733987
J Nerv Ment Dis. 1991 Oct;179(10):609-13
pubmed: 1833506
Atten Defic Hyperact Disord. 2017 Mar;9(1):47-65
pubmed: 27866355
Int J Clin Health Psychol. 2017 Jan-Apr;17(1):85-96
pubmed: 30487884
Int J Epidemiol. 2014 Dec;43(6):1815-24
pubmed: 25355726
Ment Retard Dev Disabil Res Rev. 2007;13(3):272-8
pubmed: 17910080
Pediatrics. 2007 Jul;120(1):118-33
pubmed: 17606569
Curr Psychiatry Rep. 2007 Apr;9(2):135-40
pubmed: 17389125
JAMA Pediatr. 2018 Aug 1;172(8):749-756
pubmed: 29946656
JAMA Psychiatry. 2013 Nov;70(11):1231-40
pubmed: 24068297
Dev Med Child Neurol. 2011 Mar;53(3):263-8
pubmed: 20964677
J Intellect Disabil Res. 2008 Nov;52(11):950-65
pubmed: 18179511
Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088
pubmed: 30195575
JAMA Pediatr. 2015 Dec;169(12):1162-72
pubmed: 26457641
Am J Intellect Dev Disabil. 2015 Jan;120(1):58-71
pubmed: 25551267
Clin Endocrinol (Oxf). 2009 Jul;71(1):110-4
pubmed: 18793345
Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):379-82
pubmed: 17171657
Pediatrics. 2015 Sep;136(3):e599-608
pubmed: 26304830
Eur J Intern Med. 2015 Jul;26(6):385-91
pubmed: 26025226
J Child Neurol. 2016 Jul;31(8):957-64
pubmed: 26936058
Psychiatry Res. 2011 Oct 30;189(3):440-5
pubmed: 21507490

Auteurs

Laura Del Hoyo Soriano (L)

Department of Psychiatry and Behavioral Sciences, MIND Institute University of California Davis, Sacramento, CA, USA. ldelhoyo@ucdavis.edu.

Tracie Rosser (T)

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Debra Hamilton (D)

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Taylor Wood (T)

Department of Psychiatry and Behavioral Sciences, MIND Institute University of California Davis, Sacramento, CA, USA.

Leonard Abbeduto (L)

Department of Psychiatry and Behavioral Sciences, MIND Institute University of California Davis, Sacramento, CA, USA.

Stephanie Sherman (S)

Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH